Efficacy & Safety of Drotrecogin Alfa (Activated) in Adult Patients with Septic Shock
ID Number 08-1303Principal Investigator(s)
John M. Oropello
Department(s) or Division(s)
The purpose of this research study is to examine the safety and effectiveness of the drug Xigris [drotrecogin alfa (activated)] in patients who have been diagnosed with septic shock. Septic shock is a critical condition caused by an infection in which blood pressure falls dangerously low and many organs do not work because of low blood flow.
Rosanna Del Giudice, RN
Recruiting Patients: No